AFT Pharmaceuticals: Guidance Lowered; COVID Side Effects Linger
AFT PharmaceuticalsGuidance Lowered; COVID Side Effects Linger RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) materially downgraded its FY21 EBIT...
616 Views
AFT Pharmaceuticals: 1H21 Result —Under the Weather
AFT Pharmaceuticals1H21 Result —Under the Weather RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) reported 1H21 underlying growth of ~+9%, albeit...
564 Views
AFT Pharmaceuticals: Annual Meeting Check Up
AFT PharmaceuticalsAnnual Meeting Check Up RESEARCH INSIGHTS AFT Pharmaceuticals' (AFT) Annual Meeting saw FY21 guidance for strong profit growth...
79 Views
AFT Pharmaceuticals: NZ$12m Equity Raise
AFT Pharmaceuticals NZ$12m Equity Raise RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) has announced that it is undertaking an NZ$12m equity raise to...
119 Views
AFT Pharmaceuticals: Our First Prescription
AFT Pharmaceuticals Our First Prescription RESEARCH INSIGHTS We add AFT Pharmaceuticals (AFT) to our Research Insights series — a multi-national...
127 Views